HOME
|
CONTACT
|
PATIENT LOGIN
|
CLINIC LOGIN
|
FAQ
PATIENTS &
HEALTHY VOLUNTEERS
INVESTIGATORS
CROS / SPONSORS
CAREERS
TRIAL ALERTS
TRIALS SEARCH
HEALTH NEWS
RSS FEEDS
ABOUT TRIALS
LINK TO US
Site Listing
Please choose the site that is most convenient for you
Study Name: A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
6 locations found
Dana Farber Cancer Institute
Location: Boston, Massachusetts 02115
Fox Chase Cancer Center
Location: Philadelphia, Pennsylvania 19111
University of Alabama
Location: Birmingham, Alabama 35294
University of Iowa Hospitals and Clinics
Location: Iowa City, Iowa 52242
University of Nebraska Medical Center
Location: Omaha, Nebraska 68198
UCLA
Location: Los Angeles, California 90024